Previous Close | 115.00 |
Open | 115.00 |
Bid | 110.71 x 40000 |
Ask | 119.80 x 40000 |
Day's Range | 115.00 - 115.00 |
52 Week Range | 90.24 - 123.55 |
Volume | |
Avg. Volume | 17,303 |
Market Cap | 233.064B |
Beta (5Y Monthly) | 0.50 |
PE Ratio (TTM) | 23.42 |
EPS (TTM) | 4.89 |
Earnings Date | Oct 29, 2024 |
Forward Dividend & Yield | 3.76 (3.28%) |
Ex-Dividend Date | Mar 07, 2024 |
1y Target Est | N/A |
Here are four big drug/biotech stocks, LLY, RHHBY, NVS and PFE, which you should buy today for lucrative long-term returns.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
This is the second pivotal late-stage study on SNY/REGN's Dupixent in chronic spontaneous urticaria indication to meet primary and key secondary endpoints.